Outcomes and Worsening Renal Function in Patients Hospitalized with Heart Failure with Preserved Ejection Fraction

American Journal of Cardiology

Volumn 116, Issue 10, 2015, Pages 1534-1540

  Sharma, Kavita ^a   Hill, Terence ^a   Grams, Morgan ^a   Daya, Natalie R ^a   Hays, Allison G ^a   Fine, Derek ^a   Thiemann, David R ^a   Weiss, Robert G ^a   Tedford, Ryan J ^a   Kass, David A ^a   Schulman, Steven P ^a   Russell, Stuart D ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; FUROSEMIDE; HEMOGLOBIN; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADD ON THERAPY; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLACK PERSON; BODY SURFACE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DATA BASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIURESIS; DIURETIC THERAPY; ELECTRONIC MEDICAL RECORD; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RIGHT ATRIUM PRESSURE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPERTENSION; ICD-9; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; SOCIAL SECURITY DEATH INDEX; SYSTOLIC BLOOD PRESSURE; URBAN POPULATION; URINE VOLUME; COMPLICATION; DISEASE COURSE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; INCIDENCE; INPATIENTS; MALE; MARYLAND; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84945538951     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.08.019     Document Type: Article

References (30)

1. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, A. Haouzi, Y. Gong, and P.P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
2. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
3. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. De Marco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84
4. G.C. Fonarow, W.G. Stough, W.T. Abraham, N.M. Albert, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C.W. Yancy, and J.B. Young Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
5. M. Klapholz, M. Maurer, A.M. Lowe, F. Messineo, J.S. Meisner, J. Mitchell, J. Kalman, R.A. Phillips, R. Steingart, E.J. Brown Jr., R. Berkowitz, R. Moskowitz, A. Soni, D. Mancini, R. Bijou, K. Sehhat, N. Varshneya, M. Kukin, S.D. Katz, L.A. Sleeper, and T.H. Le Jemtel Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry J Am Coll Cardiol 43 2004 1432 1438
6. B.A. Steinberg, X. Zhao, P.A. Heidenreich, E.D. Peterson, D.L. Bhatt, C.P. Cannon, A.F. Hernandez, and G.C. Fonarow Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
7. D. Rusinaru, O. Buiciuc, D. Houpe, and C. Tribouilloy Renal function and long-term survival after hospital discharge in heart failure with preserved ejection fraction Int J Cardiol 147 2011 278 282
8. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
9. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
10. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, S.S. Gottlieb, E. Loh, B.M. Massie, M.W. Rich, L.W. Stevenson, J.B. Young, and H.M. Krumholz Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
11. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
12. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, and N. Reichek Echocardiographic assessment of left-ventricular hypertrophy - comparison to necropsy findings Am J Cardiol 57 1986 450 458
13. K. Sharma, and D.A. Kass Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies Circ Res 115 2014 79 96
14. S.J. Shah Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter J Am Coll Cardiol 62 2013 1339 1342
15. K. Damman, A.C. Perez, I.S. Anand, M. Komajda, R.S. McKelvie, M.R. Zile, B. Massie, P.E. Carson, and J.J. McMurray Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment J Am Coll Cardiol 64 2014 1106 1113
16. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients J Card Fail 12 2006 257 262
17. K. Damman, M.A. Valente, A.A. Voors, C.M. O'Connor, D.J. van Veldhuisen, and H.L. Hillege Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis Eur Heart J 35 2014 455 469
18. F.H. Verbrugge, M. Dupont, P. Steels, L. Grieten, M. Malbrain, W.H. Tang, and W. Mullens Abdominal contributions to cardiorenal dysfunction in congestive heart failure J Am Coll Cardiol 62 2013 485 495
19. B.F. Palmer Renal dysfunction complicating the treatment of hypertension N Engl J Med 347 2002 1256 1261
20. M. Kawaguchi, I. Hay, B. Fetics, and D.A. Kass Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations Circulation 107 2003 714 720
21. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, G. Lewis, M.M. LeWinter, J.L. Rouleau, D.A. Bull, D.L. Mann, A. Deswal, L.W. Stevenson, M.M. Givertz, E.O. Ofili, C.M. O'Connor, G.M. Felker, S.R. Goldsmith, B.A. Bart, S.E. McNulty, J.C. Ibarra, G. Lin, J.K. Oh, M.R. Patel, R.J. Kim, R.P. Tracy, E.J. Velazquez, K.J. Anstrom, A.F. Hernandez, A.M. Mascette, and E. Braunwald Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial J Am Med Assoc 309 2013 1268 1277
22. S.J. Shah, J.F. Heitner, N.K. Sweitzer, I.S. Anand, H.Y. Kim, B. Harty, R. Boineau, N. Clausell, A.S. Desai, R. Diaz, J.L. Fleg, I. Gordeev, E.F. Lewis, V. Markov, E. O'Meara, B. Kobulia, T. Shaburishvili, S.D. Solomon, B. Pitt, M.A. Pfeffer, and R. Li Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial Circ Heart Fail 6 2013 184 192
23. K. Bibbins-Domingo, M.J. Pletcher, F. Lin, E. Vittinghoff, J.M. Gardin, A. Arynchyn, C.E. Lewis, O.D. Williams, and S.B. Hulley Racial differences in incident heart failure among young adults N Engl J Med 360 2009 1179 1190
24. C.W. Yancy, W.T. Abraham, N.M. Albert, R. Clare, W.G. Stough, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, L. She, J.L. Sun, J.B. Young, and G.C. Fonarow Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry J Am Coll Cardiol 51 2008 1675 1684
25. P. Carson, S. Ziesche, G. Johnson, and J.N. Cohn Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group J Card Fail 5 1999 178 187
26. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, and J.N. Cohn African-American Heart Failure Trial I. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
27. M.R. Bristow, G.A. Murphy, H. Krause-Steinrauf, J.L. Anderson, J.F. Carlquist, S. Thaneemit-Chen, V. Krishnan, W.T. Abraham, B.D. Lowes, J.D. Port, G.W. Davis, L.C. Lazzeroni, A.D. Robertson, P.W. Lavori, and S.B. Liggett An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure Circ Heart Fail 3 2010 21 28
28. A. Deswal, and B. Bozkurt Comparison of morbidity in women versus men with heart failure and preserved ejection fraction Am J Cardiol 97 2006 1228 1231
29. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, and J. Ostergren Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
30. R.J. Mentz, J.P. Kelly, T.G. von Lueder, A.A. Voors, C.S. Lam, M.R. Cowie, K. Kjeldsen, E.A. Jankowska, D. Atar, J. Butler, M. Fiuzat, F. Zannad, B. Pitt, and C.M. O'Connor Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction J Am Coll Cardiol 64 2014 2281 2293